OncoSil Insurance Adoption, page-12

Oz: we might be bullish on the stock but there are lots of shares and lots of sellers tomorrow at 0.9 cents. I can't see a way for the sp to get back to the 5 cents it was a year ago, much less what you are looking for. The added complication is that any entity looking at a deal will have a broker trying to keep the price as low as possible by just churning a few million shares. And if we agree more cash needs to be raised, current holders and institutions will hold off buying on market. It's a rock/hard place. If you know any wealthy individuals who are happy to build a big stake on market to be part of the next raise, call them. Or create a GameStop stampede.

Micko: I don;t think so. The GBA trial is about extending the label to folfirinox and getting public reimbursement in Germany. I don;t think they (GBA) will know about the percutaneous trial nor need to wait for the percutaneous studies.

Hopefully the company will be able to get the Notifying Body to agree to automatically extend the label to percutaneous after 30-50 applications that go safely.